BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1969994)

  • 1. Modern vaccines. Pneumococcus and influenza.
    Shann F
    Lancet; 1990 Apr; 335(8694):898-901. PubMed ID: 1969994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influenza live attenuated intra-nasal vaccines].
    Weil-Olivier C
    Arch Pediatr; 2010 Jun; 17(6):904-5. PubMed ID: 20654953
    [No Abstract]   [Full Text] [Related]  

  • 3. Modern vaccines. Enteric infections.
    Levine MM
    Lancet; 1990 Apr; 335(8695):958-61. PubMed ID: 1970034
    [No Abstract]   [Full Text] [Related]  

  • 4. [New vaccines against influenza via inhalation].
    Domínguez A; Vidal J
    Aten Primaria; 1999 Oct; 24(6):313-5. PubMed ID: 10596220
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
    J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The status of vaccinal prophylaxis against influenza today].
    Bichurina MA; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (6):104-8. PubMed ID: 9103060
    [No Abstract]   [Full Text] [Related]  

  • 7. Influenza vaccine for children.
    Neuzil KM
    Clin Infect Dis; 2004 Mar; 38(5):689-91. PubMed ID: 14986253
    [No Abstract]   [Full Text] [Related]  

  • 8. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.
    O'Hagan DT
    Clin Pharmacokinet; 1992 Jan; 22(1):1-10. PubMed ID: 1559304
    [No Abstract]   [Full Text] [Related]  

  • 10. Inactivated influenza virus vaccines in children.
    Ruben FL
    Clin Infect Dis; 2004 Mar; 38(5):678-88. PubMed ID: 14986252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.
    Keitel WA
    Semin Pediatr Infect Dis; 2002 Apr; 13(2):112-9. PubMed ID: 12122949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
    Edwards KM; Dupont WD; Westrich MK; Plummer WD; Palmer PS; Wright PF
    J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza and pneumococcal immunization of patients with neoplastic diseases.
    Brown AE
    Schweiz Med Wochenschr Suppl; 1983; 14():30-4. PubMed ID: 6581531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.
    Forrest BD; Steele AD; Hiemstra L; Rappaport R; Ambrose CS; Gruber WC
    Vaccine; 2011 May; 29(20):3633-9. PubMed ID: 21440036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal and influenza vaccination: current situation and future prospects.
    Horwood F; Macfarlane J
    Thorax; 2002 Oct; 57 Suppl 2(Suppl 2):II24-II30. PubMed ID: 12364707
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics.
    Sano K; Ainai A; Suzuki T; Hasegawa H
    Expert Rev Vaccines; 2018 Aug; 17(8):687-696. PubMed ID: 30092690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine 2005-2006.
    Med Lett Drugs Ther; 2005 Oct; 47(1220):85-7. PubMed ID: 16264371
    [No Abstract]   [Full Text] [Related]  

  • 19. Removing barriers to vaccination use by older adults.
    Richardson JP; Michocki RJ
    Drugs Aging; 1994 May; 4(5):357-65. PubMed ID: 8043938
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing protection against influenza in children eligible for the vaccine for children program.
    Hull HF; O'Connor H
    Pediatr Infect Dis J; 2010 Oct; 29(10):910-4. PubMed ID: 20431426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.